Influenza, Respiratory Vaccines

Recent Advancement in Influenza Vaccine

Submit Abstract Register Now

Influenza can induce serious Acute respiratory distress syndrome (ARDS) and non-conventional treatment like extracorporeal membrane oxygenation (ECMO), can be safely instituted in highly specialized centres. Due to a rapid progression of respiratory failure, transfer of these patients to a referral centre on mechanical ventilation is often infeasible. Therefore the start of ECMO flu treatment and care at the peripheral hospitals and transportation on ECMO could be a viable option. The creation of an ECMO team, with experts in the treatment of ARDS, seems a key aspect for the safe management of these patients, including when the most advanced technique are not immediately available.

With the grand success of Vaccines Asia Pacific 2015 conference, Conference Series LLC is organizing the “5th Annual Congress on Influenza, Respiratory Diseases & Infections: Vaccines and Therapeutics (IRDI Vaccines 2016)” will be scheduled during December 01-02, 2016 at Atlanta, USA. IRDI Vaccines 2016 bring together the Global leaders in Immunology and relevant fields to present their research at this exclusive scientific program. IRDI Vaccines 2016 Organizing Committee also invites Young investigators at every career stage to submit abstracts reporting their latest scientific findings in oral and poster sessions.